Roche's offer for Genentech surprises workers, analysts

07/21/2008 | Wall Street Journal, The · CNNMoney · Reuters

Genentech's executives have not commented on Roche Holding's $43.7 billion takeover bid, but some employees are concerned that the offer was too sudden and could unsettle the companies' partnership. Analysts expect Roche to make a higher bid, one that reflects the potential of the U.S. biotech firm's pipeline. Roche's move could encourage other major drugmakers to consider acquiring profitable biotech pioneers, industry experts said.

View Full Article in:

Wall Street Journal, The · CNNMoney · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA